北京
分享至
康希诺(688185.SH)发布公告，公司的ACYW135群脑膜炎球菌多糖结合疫苗(CRM197载体)(简称“MCV4”)药品补充申请于近日获得国家药品监督管理局出具的《受理通知书》，受理号：CYSB2400306。
本文源自：金融界AI电报
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
